Deargen Companies

Deargen provides AI-based genome analysis service.

Founded Date: 2016-12-06
Last Funding Type: Series B
Headquarters: Daejeon, Taejon-jikhalsi, South Korea
Investors Number: 6.0
Technology: COVID
Employee Number: 11-50
Industry: BioTech & Health Care
Last Funding Date: 2022-02-24
Number Of Exists: N/A
Funding Status: Early Stage Venture
Investor Type: N/A
Investment Stage: N/A
Total Funding: 19647275.0